NEVVI Medicare utilization intelligence
or browse by specialty
Medicare · fee-for-service Part B

Endocrinology — Medicare Part B billing by state

$0.09B
Medicare payments
208
Physician groups
2,780,388
Services

208 physician groups whose primary specialty is Endocrinology billed $0.09B to Medicare fee-for-service in 2024.

Calendar year 2024 · Medicare fee-for-service Part B

Physician groups whose primary specialty is Endocrinology, by billing state · CY2024
State Groups Services Beneficiary-episodes Medicare payments Standardized payments ↓ Payments / group Services / group
Texas 36 494,115 191,448 $16,079,236 $16,335,608 $446,645 13,725
Florida 32 440,462 198,243 $14,419,946 $14,052,173 $450,623 13,764
New York 17 448,839 200,164 $12,605,106 $11,438,571 $741,477 26,402
California 18 236,031 105,437 $8,362,901 $7,862,483 $464,606 13,113
New Jersey 12 309,814 122,754 $8,157,796 $7,735,629 $679,816 25,818
Virginia 7 177,357 39,341 $3,978,425 $3,913,852 $568,346 25,337
Michigan 15 72,624 32,201 $3,699,616 $3,625,349 $246,641 4,842
Arizona 6 99,958 60,341 $3,182,935 $3,259,825 $530,489 16,660
Maryland 3 66,560 24,537 $2,584,679 $2,407,823 $861,560 22,187
Mississippi 3 72,667 44,811 $1,644,204 $1,759,291 $548,068 24,222
Missouri 5 32,768 14,881 $1,546,691 $1,623,908 $309,338 6,554
South Carolina 6 28,821 15,530 $1,497,952 $1,536,217 $249,659 4,804
Georgia 5 32,188 16,881 $1,499,802 $1,511,164 $299,960 6,438
Illinois 8 24,181 11,298 $1,534,572 $1,488,339 $191,822 3,023
Pennsylvania 8 39,554 9,574 $1,422,842 $1,384,883 $177,855 4,944
Massachusetts 3 29,276 15,391 $1,266,501 $1,225,498 $422,167 9,759
Nevada 3 15,289 8,468 $1,099,350 $1,133,672 $366,450 5,096
North Carolina 4 19,550 10,834 $928,324 $983,254 $232,081 4,888
Oregon 2 31,876 14,229 $882,006 $853,793 $441,003 15,938
Tennessee 3 10,916 5,971 $658,379 $711,912 $219,460 3,639
Louisiana 4 9,878 6,360 $661,606 $703,534 $165,402 2,470
Connecticut 1 21,872 4,236 $703,833 $657,979 $703,833 21,872
Rhode Island 1 25,817 15,051 $585,082 $577,976 $585,082 25,817
Colorado 3 8,260 5,419 $530,595 $535,285 $176,865 2,753
Delaware 1 5,439 3,531 $422,460 $426,510 $422,460 5,439
Maine 1 764 383 $400,211 $382,777 $400,211 764
Minnesota 2 4,887 2,305 $258,862 $269,334 $129,431 2,444
Indiana 1 3,240 2,137 $203,259 $219,954 $203,259 3,240
Washington 1 3,842 2,199 $191,125 $190,663 $191,125 3,842
Hawaii 1 2,894 1,541 $160,270 $161,400 $160,270 2,894
Kansas 1 2,007 1,119 $133,788 $140,609 $133,788 2,007
Ohio 3 2,172 1,139 $111,426 $118,733 $37,142 724
PR 5 1,503 865 $114,098 $114,580 $22,820 301
Alabama 1 1,543 844 $109,079 $112,890 $109,079 1,543
West Virginia 1 1,146 892 $92,764 $104,573 $92,764 1,146
Idaho 1 1,383 871 $68,344 $74,118 $68,344 1,383
New Hampshire 1 31 13 $43,443 $43,505 $43,443 31
Wisconsin 1 312 226 $24,176 $25,762 $24,176 312
Utah 1 252 206 $17,646 $18,749 $17,646 252
Oklahoma 1 165 143 $7,210 $6,877 $7,210 165
District of Columbia 1 72 28 $4,428 $3,947 $4,428 72
AP 1 63 50 $3,314 $3,371 $3,314 63
Ranked by standardized payments — the cross-state basis (regional price differences removed). The Medicare payments column shows what Medicare actually paid. Each state opens the ranked Endocrinology market for that state's biggest code.

Need this specialty's market in one document?

Notify me at launch

Each group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.

All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.

Top codes by Medicare payments CY2024

Code Services Medicare payments ↓ Largest state markets
99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 359,733 $32,812,435 TXFLNYCANJ
J0897 · Injection, denosumab, 1 mg 360,951 $7,375,576 TXFLNYCANJ
99215 · Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more 42,784 $5,577,137 TXFLNYCANJ
99213 · Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more 58,452 $3,751,075 TXFLNYCANJ
99204 · New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more 23,276 $2,778,873 TXFLNYCANJ
99232 · Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 41,434 $2,665,908 TXFLNYCANJ
76536 · Ultrasound scan of head and neck soft tissue 31,830 $2,586,221 TXFLNYCANJ
95251 · Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 89,471 $2,302,084 TXFLNYCANJ
99490 · Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month 36,587 $1,759,741 TXFLNYCANJ
G2211 · Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's 111,621 $1,396,438 TXFLNYCANJ
J3111 · Injection, romosozumab-aqqg, 1 mg top by services 162,751 $1,380,866 TXFLNYCANJ
84443 · Blood test, thyroid stimulating hormone (tsh) top by services 82,781 $1,357,963 TXFLNYCANJ
83036 · Hemoglobin a1c level top by services 93,599 $885,217 TXFLNYCANJ
80061 · Blood test, lipids (cholesterol and triglycerides) top by services 66,581 $869,200 TXFLNYCANJ
36415 · Insertion of needle into vein for collection of blood sample top by services 106,332 $853,115 TXFLNYCANJ
80053 · Blood test, comprehensive group of blood chemicals top by services 73,961 $762,002 TXFLNYCANJ
Top codes by Medicare payments and by services (both rankings, duplicates merged; capped, never the full code list). “top by services” marks codes here on service volume rather than payments. Each code is searchable free at full depth; state links open that code's ranked market page.

Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.

Notify me at launch